PDC*line Pharma presents first clinical results from Phase I/II trial with PDC*lung01 at ESMO 2022
Yposkesi reinforces team with three executive appointments
Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product
ABL and Coave Therapeutics enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy
BCI Pharma enters into strategic partnership with Mithra to identify novel therapy for endometriosis and cancer in women
BCI Pharma seeks to expand its library of kinase inhibitors and address innovative mechanisms of action for unmet medical needs
Contipharma launches saliva-based Omicron detecting PCR test in Africa
Developed by University of Liège in Belgium, only test of its kind available on African continent
First contracts signed with Democratic Republic of Congo, Burundi and Sudan
Limbach Group adopts QuantaMatrix dRAST™ in routine clinical use
QuantaMatrix’s direct Rapid Antimicrobial Susceptibility Testing system (dRAST) improves optimal prescription of antibiotics by two days compared to conventional methods
Following successful validation of dRAST platform in Europe at key reference laboratories, system now adopted for clinical use
Ferrer and CNIC unveil results of first real-world study of cnic-polypill showing decreased risk of major adverse cardiovascular events when compared to monocomponents administered separately
